Cyclic amide derivatives as potential prodrugs II: N- hydroxymethylsuccinimide- / isatin esters of some NSAIDs as prodrugs with an improved therapeutic index

European Journal of Medicinal Chemistry

Volumn 34, Issue 7-8, 1999, Pages 551-562

  Mahfouz, Nadia M ^a   Omar, Farghaly A ^a   Aboul Fadl, Tarek ^a  

^a Assiut University   (Egypt)

Author keywords

In vitro stability; Lipophilicity; N hydroxy methylisatin (HMIS); N hydroxymethylsuccinimide (HMSI); NSAI prodrugs; Ulcerogenicity

Indexed keywords

AMIDE; N HYDROXYMETHYLSUCCINIMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PRODRUG; SUCCINIMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BIOAVAILABILITY; CELL PROTECTION; DERIVATIZATION; DRUG STABILITY; DRUG SYNTHESIS; ENZYME DEGRADATION; GASTROINTESTINAL TOXICITY; SCANNING ELECTRON MICROSCOPY; STOMACH MUCOSA; TARGET CELL;

EID: 0032710426     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(00)80025-2     Document Type: Article

References (26)

1. Vane J.R. Nature. 231:1971;232-235.
2. Shoen R.T., Vender R.J. Am. J. M. 86:1989;449-458.
3. Cioli V., Putzolu S., Rossi V., Barcellonu P.S., Corradino C. Toxicol. Appl. Pharmacol. 50:1979;283-289.
4. Shanbhag V.R., Harpalani A., Dick R.M. J. Pharm. Sci. 81:1992;149-154.
5. Bodor N. Pharmazie. 52:1997;491-494.
6. Moreira R., Calheiros T., Mendes E., Pimentel M., Iley J. Pharm. Res. 13:1996;70-75.
7. Omar F.A. Eur. J. Med. Chem. 33:1998;123-131.
8. Glover V., Halket J.M., Watkins P.J., Clow A., Goodwin B.L., Sandler M.J. Neurochem. 51:1988;656-659.
9. vonMuller M. Med. Exp. 7:1962;155-160.
10. Saari W.S., Freedman M.B., Hartman R.D., King S.W., Raab A.W., Randall W.C., Engelhardt E.L., Hirschmann R. J. Med. Chem. 21:1978;746-753.
11. Nielsen N.M., Bundgaard H. J. Med. Chem. 32:1989;727-734.
12. Butcher M. Org. Mass Spectrom. 5:1971;759-763.
13. Khans A.H., Bundgaard H. Int. J. Pharm. 62:1990;193-205.
14. Bundgaard H., Nielsen N.M. Int. J. Pharm. 44:1988;151-158.
15. Iley J., Moreira R., Ross E. J. Chem. Soc. Perkin Trans. 2:1991;563-570.
16. Mannhold R., Rekker R.F., Sonntag C., TerLaak A.M., Dross K., Polymeropoulus E.E. J. Pharm. Sci. 84:1995;1410-1419.
17. Leo A.J. Chem. Rev. 93:1993;1281-1306.
18. Kubinyi H. Prog. Drug Res. 23:1979;97-198.
19. Leo A.J., Hansch C. J. Org. Chem. 36:1971;1539-1545.
20. Moriguchi I., Hirono S., Liu Q., Nakagome I., Matsushita Y. Chem. Pharm. Bull. 40:1992;127-130.
21. Tammara V.K., Narurkar M.M., Crider A.M., Khan M.A. Pharm. Res. 10:1993;1191-1199.
22. Ogiso T., Iwaki M., Tanino T., Nagai T., Ueda Y., Muraoka O., Tanabe G. Biol. Pharm. Bull. 19:1996;1178-1183.
23. Omar F.A., Mahfouz N.M., Rahman M. Eur. J. Med. Chem. 31:1996;819-825.
24. Fadl T.A., Omar F.A. Inflammopharmacology. 6:1998;143-157.
25. Borrows E.T., Johnson J.M., Brit. Patent 1, 220, 447, (1971); through ref. 11.
26. Buu-Hoi N.P., Saint-Ruf G., Perche J.C., Bourgeade J.C. Chem. Ther. 3:1968;110-113.